Large congenital facial teratoma
- 1 General Surgery, Santa Casa de Misericordia, Porto Alegre, RS, Brazil
- 2 Head and neck, Instituto de la Tiroides y Enfermedades de Cabeza y Cuello, Quito, Ecuador
- 3 Universidad San Francisco de Quito, Quito, Pichincha, Ecuador
- Correspondence to Dr Paola Solis-Pazmino; paosolpaz18@gmail.com
Abstract
This case report discusses a presentation of a giant facial teratoma, a rare congenital neoplasm. Head and neck locations of the tumour uncommonly distort the face and may be associated with functional problems. We present a case of teratoma arising from the right parotid extending to the extracranial regions, successfully managed by surgical resection. Reviewing this case with the supporting body of literature anticipates further investigation to address patients’ needs more thoroughly.
Background
Teratomas are rare congenital neoplasms originating from all three germinal cell layers. They are even rare in the head and neck, which account for only 2%, and those with extracranial or intracranial extensions are very unusual.1 This feature confers high mortality, and those who have had surgery have mostly remained with varying degrees of morbidity.2 Moreover, one of the most frequent complications of paediatric head and neck teratomas is airway compromise.3 We present a case of a giant congenital facial teratoma that was managed with a complete surgical resection.
Case presentation
A baby boy was brought with a large right mass present since birth. He was born by caesarean section of a primiparous woman, gravida 0, para 0, at the 38th week, with one live and healthy issue at term gestation. Antenatal ultrasound reported an elongated facial appendage measuring 54×23×49 mm (L×H×W) and volume 32 mL, which was noted to be arising from the right parotid (figure 1A). It was a smooth, hypodense cystic lesion and did not concern vascularity on colour Doppler imaging (figure 1B).
(A) Ultrasound reported an elongated facial appendage measuring 54×23×49 mm (L×B×W) and volume 32 mL. (B) Hypodense cystic lesion not concerning vascularity on colour Doppler imaging.

The fetus followed an average overall growth, the patient was confined by elective caesarean section at term and the neonate was delivered in good overall condition.
According to the parents, the child had no pain, difficulty chewing food and opening his mouth, difficulty in hearing or other neurological deficits.
On examination, the mass occupied the lateral part of the face and measured about 6.5×5×4 cm (figure 2), extending superiorly to the right pterygoid region to the submaxillary ipsilateral.
The right mass on the face measures about 6.5×5×4 cm.

Investigations
Contrast-enhanced CT with the reconstruction of the head and neck showed a large extracranial well-defined rounded hypodense (12 Hu) intensity mass lesion measuring approximately 6.5×5×4 cm along the right submaxillary (figure 3).
Large extracranial well-defined rounded hypodense (12 Hu) intensity mass lesion measuring approximately 6.5×5×4 cm along the right submaxillary.

The three-dimensional biomodel reconstruction used in this case was performed using CT of the anatomical area. This technique allowed the doctor–patient communication since it allowed the latter to have a better understanding of their pathology and the suggested procedure (https://sketchfab.com/3d-models/contento-a812f3a347984e8e991c5f25714d0637).
Differential diagnosis
The differential diagnoses include cystic hygroma, a benign tumour that originates from the obstruction of the drainage of the lymphatic sacs4; a cyst of the thyroglossal duct, which is embryological remains of an evagination of the endoderm in the migration path of the thyroid gland; and hamartoma, which is a mature tissue structure resulting from the involvement of one of the three germ layers compared with teratoma involving all three layers.3
Treatment
The boy underwent surgical removal of the teratoma at 16 months of age. The tumour was successfully revealed using a lateral facial approach, where a preauricular and temporal incision was made to access it (figure 4A). There was a large cystic mass of about 7×5×4 cm in the right submaxillary area extending to the cheek, with no visual deficit in the skull. Posteriorly, the mass was densely adherent to the anterior wall of the parotid, which was gradually teased off. The facial muscles were thinned out and stretched over the mass to remove the tumour, integrating them into certain tumour areas.
(A) The right submaxillary facial incision was made over the mass, extending to the infraorbital region. (B) Excision of the mass and closure.

Furthermore, the facial nerve branches were also stretched over the tumour. The excision of the entire tumour was performed with utmost care to preserve as much muscle and nerve tissue as possible. Excess skin was excised and closed (figure 4B). We used an intraoperative device for facial nerve monitoring to identify and minimise facial nerve injury.
Postoperatively, the patient received intravenous analgesics and antibiotics. He recovered well with no neurological deficit or wound infection and was discharged on postoperative day 2.
The histopathology report showed a mature cystic teratoma lesion filled with yellow fluid with an intact capsule. The tumour had squamous, ciliated columnar, intestinal epithelium, neuronal tissue, gastric tissue, salivary gland, lymphoid follicles, adipose tissue, muscle bundles, foamy macrophages, multiple congestive capillaries and blood vessels, hyaline cartilage and nerve fillets of variable sizes, generating images reminiscent of nerve plexuses (figure 5A,B).
(A) The tumour had squamous, ciliated columnar, intestinal epithelium, muscle bundles and foamy macrophages. (B) The tumour had hyaline cartilage and nerve fillets of variable sizes, generating images reminiscent of nerve plexuses.

Outcome and follow-up
The patient had an unremarkable recovery period, and he has been on follow-up for 28 months now and is doing well with no recurrent growth or neurological or sensitive deficits (figure 6).
Patient recovery and follow-up.

Discussion
Craniocervical teratomas are congenital tumours derived from the three germ cell layers: endoderm, mesoderm and ectoderm. The incidence is 1 in 40 000 live births.5 They are predominant in the female population, with 75%.6 They are uncommon, being the sacrococcygeal region the most frequent location. Nevertheless, head and neck teratomas are unusual.7 Our baby boy has a facial teratoma with extracranial extension.
The symptoms of facial teratoma can vary depending on the size, location and specific tissue types present within the tumour. Some common symptoms of facial teratoma include facial paralysis or weakness, vision or hearing problems, difficulty breathing or swallowing, and deformities or asymmetry in the face. In some cases, the tumour may grow into the brain, causing neurological symptoms such as headaches, seizures or changes in mental status.
Facial teratomas are relatively rare and can be challenging to treat due to their location in the face. However, many patients can achieve a good outcome with early diagnosis and treatment. Complete surgical resection of the lesion from the intracranial and extracranial cavities is essential to prevent mortality and morbidity.8 Additionally, the surgical removal of facial teratoma can sometimes cause scarring, nerve damage or other surgical complications. The diagnosis in our patient was in the prenatal period. However, the surgical treatment was performed at 16 months with successful results. Rapid advances in imaging and instrumentation technology have led to the development of novel tools allowing the surgeon to more accurately locate critical structures, anticipate intraoperative challenges and select the best surgical approach.9 The histopathology in craniocervical teratomas is commonly mature, like our patient. A teratoma’s mortality rate depends on its location, size and histological grade.10 Our patient had an extracranial extension which gives high mortality, although he had a successful surgery. The patient has had an excellent postoperative recovery and was recurrence-free on a 28-month follow-up.
Facial teratoma can have sociocultural implications for affected individuals and their families. In some cultures, physical appearance and facial symmetry are highly valued, and facial teratomas can cause significant social stigma and discrimination. Individuals with facial teratomas may experience teasing, bullying or social isolation, leading to psychological distress and low self-esteem. Additionally, the cost of medical treatment for facial teratoma can be a significant financial burden for families, especially in countries without access to comprehensive healthcare coverage.
Patient’s perspective
My son was first noted to have a multilocular cystic lesion in the right cheek region during a routine obstetric ultrasound. Following his delivery by a C-section without complications, I was scared about the care he should receive. My husband was so sad because we had never heard about facial teratoma. Amid his upbringing, he did not notice any pain, difficulties with hearing, opening the mouth, eating, or any other deficiency associated with the nervous system. He was able to carry out all his activities. When we decided that the surgery was best for our son, we trusted in the process, and it was successful. Looking at my son without that mass, I feel happy because he looks great. He always needs a follow-up, and my family supports him.
Learning points
-
Addressing the sociocultural aspects of facial teratoma requires a comprehensive approach that includes medical care, psychological support and education about the condition to reduce the stigma and discrimination associated with this condition.
-
Management is a complex and challenging procedure. Therefore, a multidisciplinary expert team is critical to success, and it requires an understanding of the types of lesions and knowledge of the best surgical approach.
-
Using a three-dimensional printed model facilitated operative planning and minimised blood loss during debulking.
Ethics statements
Patient consent for publication
Footnotes
-
Contributors PS-P and CG conceived and designed the work. PS-P and CP-C drafted the manuscript. PS-P and CG made data collection. VS and CP-C made corrections and final article review. All authors read and approved the final manuscript version to be published. CG agrees to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
-
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
-
Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.
-
Competing interests None declared.
-
Provenance and peer review Not commissioned; externally peer reviewed.
- © BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.
References
Use of this content is subject to our disclaimer